Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 9701574, 8 pages
http://dx.doi.org/10.1155/2016/9701574
Clinical Study

Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients

Department of Gastroenterological Surgery, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan

Received 1 June 2015; Accepted 15 July 2015

Academic Editor: Jason S. Gold

Copyright © 2016 Kazuyoshi Shiga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. E. Dukes, “The classification of cancer of the rectum,” The Journal of Pathology and Bacteriology, vol. 35, no. 3, pp. 323–332, 1932. View at Publisher · View at Google Scholar
  2. M. P. Nowacki, P. Janik, and P. M. Nowacki, “Inflammation and metastases,” Medical Hypotheses, vol. 47, no. 3, pp. 193–196, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Pagès, J. Galon, M.-C. Dieu-Nosjean, E. Tartour, C. Sautès-Fridman, and W.-H. Fridman, “Immune infiltration in human tumors: a prognostic factor that should not be ignored,” Oncogene, vol. 29, no. 8, pp. 1093–1102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. McMillan, K. Canna, and C. S. McArdle, “Systemic inflammatory response predicts survival following curative resection of colorectal cancer,” British Journal of Surgery, vol. 90, no. 2, pp. 215–219, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Sharma, M. Zucknick, R. London, M. Kacevska, C. Liddle, and S. J. Clarke, “Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer,” Clinical Colorectal Cancer, vol. 7, no. 5, pp. 331–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. C. McMillan, J. E. M. Crozier, K. Canna, W. J. Angerson, and C. S. McArdle, “Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer,” International Journal of Colorectal Disease, vol. 22, no. 8, pp. 881–886, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. W. Wu, S. R. Wang, M. F. Chao et al., “Serum interleukin-6 levels reflect disease status of gastric cancer,” The American Journal of Gastroenterology, vol. 91, no. 7, pp. 1417–1422, 1996. View at Google Scholar · View at Scopus
  8. M. Łukaszewicz-Zaja̧c, B. Mroczko, M. Gryko, B. Kędra, and M. Szmitkowski, “Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer,” Clinical and Experimental Medicine, vol. 11, no. 2, pp. 89–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Oka, K. Yamamoto, M. Takahashi et al., “Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma,” Cancer Research, vol. 56, no. 12, pp. 2776–2780, 1996. View at Google Scholar · View at Scopus
  10. H. Yanagawa, S. Sone, Y. Takahashi et al., “Serum levels of interleukin 6 in patients with lung cancer,” British Journal of Cancer, vol. 71, no. 5, pp. 1095–1098, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Nakashima, M. Tachibana, Y. Horiguchi et al., “Serum interleukin 6 as a prognostic factor in patients with prostate cancer,” Clinical Cancer Research, vol. 6, no. 7, pp. 2702–2706, 2000. View at Google Scholar · View at Scopus
  12. G.-J. Zhang and I. Adachi, “Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma,” Anticancer Research, vol. 19, no. 2, pp. 1427–1432, 1999. View at Google Scholar · View at Scopus
  13. Y. Kanda, “Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics,” Bone Marrow Transplantation, vol. 48, no. 3, pp. 452–458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Belluco, D. Nitti, M. Frantz et al., “Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer,” Annals of Surgical Oncology, vol. 7, no. 2, pp. 133–138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. B. H. Al-Ghurabi, “The role of serum IL-6 in colorectal cancer patients and it’s relationship with serum CEA level,” Journal of the Faculty of Medicine, vol. 51, no. 4, pp. 403–406, 2009. View at Google Scholar
  16. D. Mazhar and S. Ngan, “C-reactive protein and colorectal cancer,” QJM, vol. 99, no. 8, pp. 555–559, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Nozoe, T. Matsumata, M. Kitamura, and K. Sugimachi, “Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer,” The American Journal of Surgery, vol. 176, no. 4, pp. 335–338, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Buchholz, R. S. Chanthaphavong, T. R. Billiar, and A. J. Bauer, “Role of interleukin-6 in hemopoietic and non-hemopoietic synergy mediating TLR4-triggered late murine ileus and endotoxic shock,” Neurogastroenterology and Motility, vol. 24, no. 7, pp. e658–e294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. X.-Z. Shi and S. K. Sarna, “Transcriptional regulation of inflammatory mediators secreted by human colonic circular smooth muscle cells,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 289, no. 2, pp. G274–G284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. H. Edmiston, A. Gangopadhyay, Y. Shoji, A. P. Nachman, P. Thomas, and J. M. Jessup, “In vivo induction of murine cytokine production by carcinoembryonic antigen,” Cancer Research, vol. 57, no. 19, pp. 4432–4436, 1997. View at Google Scholar · View at Scopus
  21. A. Gangopadhyay, O. Bajenova, T. M. Kelly, and P. Thomas, “Carcinoembryonic antigen induces cytokine expression in Kuppfer cells: implications for hepatic metastasis from colorectal cancer,” Cancer Research, vol. 56, no. 20, pp. 4805–4810, 1996. View at Google Scholar · View at Scopus
  22. C. Giessen, D. Nagel, M. Glas et al., “Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer,” Tumour Biology, vol. 35, no. 10, pp. 10237–10248, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Huang, J. S. Liu, and J. F. Feng, “The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis,” OncoTargets and therapy, vol. 8, pp. 795–803, 2015. View at Google Scholar
  24. K. A. Kwon, S. H. Kim, S. Y. Oh et al., “Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer,” BMC Cancer, vol. 10, article 203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Hashimoto, M. Itabashi, S. Ogawa et al., “Sub-classification of Stage II colorectal cancer based on clinicopathological risk factors for recurrence,” Surgery Today, vol. 44, no. 5, pp. 902–905, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Cakar, U. Varol, B. Junushova et al., “Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer,” Journal of BUON, vol. 18, no. 2, pp. 372–376, 2013. View at Google Scholar · View at Scopus
  27. S. Hatano, H. Ishida, K. Ishibashi, K. Kumamoto, N. Haga, and I. Miura, “Identification of risk factors for recurrence in high-risk stage II colon cancer,” International Surgery, vol. 98, no. 2, pp. 114–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Kinoshita, H. Ito, and C. Miki, “Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma,” Cancer, vol. 85, no. 12, pp. 2526–2531, 1999. View at Google Scholar · View at Scopus
  29. Y.-C. Chung and Y.-F. Chang, “Serum interleukin-6 levels reflect the disease status of colorectal cancer,” Journal of Surgical Oncology, vol. 83, no. 4, pp. 222–226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. K.-Y. Yeh, Y.-Y. Li, L.-L. Hsieh et al., “Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer,” Japanese Journal of Clinical Oncology, vol. 40, no. 6, Article ID hyq010, pp. 580–587, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-C. Chung, Y.-L. Chaen, and C.-P. Hsu, “Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma,” Anticancer Research, vol. 26, no. 5, pp. 3905–3911, 2006. View at Google Scholar · View at Scopus